Stockscreener 앱 받기
60.13
2.00%
-1.23
시간 외 거래:
60.13
Guardant Health Inc 주식(GH)의 최신 뉴스
New Blood Test Algorithm Shows Sensitivity, Specificity in CRC Screening - CancerNetwork
Live market analysis of Guardant Health Inc.July 2025 Opening Moves & Weekly High Return Stock Forecasts - Newser
Canaccord Genuity Remains a Buy on Guardant Health (GH) - The Globe and Mail
Is Guardant Health Inc. a turnaround storyEarnings Recap Summary & Weekly Watchlist for Hot Stocks - خودرو بانک
Growth Review: How does Guardant Health Inc. score in quality rankingsJuly 2025 PreEarnings & Fast Gain Stock Trading Tips - خودرو بانک
What to expect from Guardant Health Inc. in the next 30 daysMarket Performance Report & Community Shared Stock Ideas - Newser
Is Guardant Health Inc. showing signs of accumulationBull Run & Free Weekly Watchlist of Top Performers - Newser
Guardant Health reports positive clinical readout update for Shield algorithm - Yahoo Finance
Guardant Health Announces Clinical Result Update for Shield Blood-Based Colorectal Cancer Screening Test - biospace.com
Signal strength of Guardant Health Inc. stock in tech scannersJuly 2025 Patterns & Smart Swing Trading Techniques - Newser
Detecting price anomalies in Guardant Health Inc. with AIOptions Play & Real-Time Volume Spike Alerts - Newser
Multi asset correlation models including Guardant Health Inc.2025 Support & Resistance & Safe Swing Trade Setups - Newser
Volume spikes in Guardant Health Inc. stock – what they meanJuly 2025 Sentiment & Community Trade Idea Sharing - Newser
Guardant Health Surges to $280M in Volume as Stock Plunges 5.69% to 378th Rank - AInvest
The Oncology Institute, Inc. shares rise 1.70% intraday after Guardant Health's positive clinical readout update for its Shield™ blood test. - AInvest
Guardant Health shares drop 9% after data release for Shield colorectal cancer screening test. - AInvest
Guardant Health Stock Falls on Colorectal Cancer Test UpdateNews and Statistics - IndexBox
Why Guardant Health (GH) Shares Are Plunging Today - Yahoo Finance
Guardant Health: BTIG Maintains Buy, Raises PT to $70 from $65 - AInvest
Why IBD 50's Guardant Health Just Tumbled, Breaking A 67% Monthlong Run - inkl
Guardant Health stock falls 8% despite Evercore ISI’s positive outlook - Investing.com
Guardant Health Updates Results for Shield Blood Test in Colorectal Cancer - MarketScreener
Guardant Health Plunges 11.05% Amid Insider Trading Concerns - AInvest
Guardant drops after trial data for cancer test (GH:NASDAQ) - Seeking Alpha
What drives Guardant Health Inc.’s stock priceJuly 2025 Rallies & Risk Controlled Swing Alerts - خودرو بانک
Guardant Health’s Shield blood test shows 84% sensitivity for colorectal cancer - Investing.com
Guardant Health Updates Shield Blood-Based Colorectal Cancer Screening Test with New Algorithm - AInvest
Liquid Biopsy Market to Hit USD 24.70 Billion by 2033 | Key Players - openPR.com
When is the best time to exit Guardant Health Inc.Earnings Overview Report & Daily Technical Stock Forecast Reports - Newser
How to read the order book for Guardant Health Inc.July 2025 Catalysts & Fast Exit Strategy with Risk Control - Newser
What to do if you’re stuck in Guardant Health Inc.Insider Buying & Fast Gain Stock Trading Tips - Newser
How volatile is Guardant Health Inc. stockPortfolio Risk Summary & Low Risk Investment Opportunities - خودرو بانک
Technical signs of recovery in Guardant Health Inc.2025 Price Momentum & High Return Stock Watch Alerts - Newser
Is it too late to sell Guardant Health Inc.IPO Watch & Advanced Swing Trade Entry Plans - Newser
Joyce, Guardant Health director, sells $6,584 in shares - Investing.com
Using flow based indicators on Guardant Health Inc.2025 Investor Takeaways & Long-Term Safe Investment Plans - Newser
Joyce, Guardant Health director, sells $6,584 in shares By Investing.com - Investing.com UK
Guardant Health Director Sells 100 Shares at $65.84 on 2025-09-02 - AInvest
Liquid Biopsy in Cancer Diagnostics Market to Witness Robust ~17% CAGR Expansion by 2032 | DelveInsight - Barchart.com
Is Guardant Health Inc. stock ready for a breakoutPortfolio Performance Summary & Stepwise Trade Execution Plans - Newser
Analyzing recovery setups for Guardant Health Inc. investors2025 Top Gainers & Risk Managed Trade Strategies - Newser
How to recover losses in Guardant Health Inc. stockPortfolio Update Summary & Stepwise Swing Trade Plans - Newser
Guardant Health Inc. stock daily chart insightsJuly 2025 Earnings & Real-Time Sentiment Analysis - Newser
Is It Too Late to Sell Guardant Health Inc.2025 Big Picture & Daily Technical Forecast Reports - beatles.ru
Automated trading signals detected on Guardant Health Inc.Weekly Gains Report & Capital Efficiency Focused Strategies - Newser
Breakthrough Cancer Therapies Fuel Regulatory Momentum as Global Market Expands - Eastern Progress
Will Guardant Health Inc. stock split in the near futureMarket Weekly Review & Weekly Momentum Picks - Newser
Is GH's Q1 2025 forecast achievable? - AInvest
Advanced analytics toolkit walkthrough for Guardant Health Inc.Analyst Downgrade & Weekly Top Gainers Alerts - Newser
Cyted Health’s $44M Series B: A Strategic Bet on Early Cancer Detection and Global Expansion - AInvest
Liquid Biopsy Market Trends and Industry Forecast to 2030 - GlobeNewswire
Will Guardant Health Inc. see short term momentumTrade Volume Summary & Growth Focused Stock Reports - Newser
What’s the analyst consensus on Guardant Health Inc.Rate Cut & Free Real-Time Market Sentiment Alerts - خودرو بانک
Is Guardant Health Inc. impacted by rising ratesQuarterly Profit Review & Smart Money Movement Alerts - خودرو بانک
Will Guardant Health Inc. bounce back from current supportJuly 2025 PreEarnings & Intraday High Probability Setup Alerts - Newser
Guardant Health Inc. stock prediction for this weekTreasury Yields & Technical Analysis for Trade Confirmation - Newser
2.21%
자본화:
|
볼륨(24시간):